Impact of the Innovative Medicines Initiative on vaccine development
Nat Rev Drug Discov
.
2018 Nov;17(11):769-770.
doi: 10.1038/nrd.2018.72.
Epub 2018 Jun 1.
Authors
Philippe Denoel
1
,
Patricia Londoño-Hayes
2
,
Magda Chlebus
3
,
Magdalena Rodriguez de Azero
4
Affiliations
1
GSK, Rixensart, Belgium.
2
Sanofi Pasteur, Marcy-l'Étoile, France.
3
European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium.
4
Vaccines Europe/EFPIA, Brussels, Belgium.
PMID:
29853715
DOI:
10.1038/nrd.2018.72
No abstract available
MeSH terms
Drug Development / methods
Drug Industry / methods
Europe
Humans
Vaccines / chemistry*
Substances
Vaccines